| Bioactivity | PPARγ agonist 14 (compound 3) is a PPARy agonist (EC50=2.4 μM) with anti-diabetic activity. PPARγ agonist 14 can improve intracellular glucose uptake, promote insulin release, and lower blood sugar. In addition, PPARγ agonist 14 also improves mitochondrial function, reduces oxidative stress, and inhibits inflammatory factors. PPARγ agonist 14 can be used in the study of neurodegenerative diseases, neuroinflammatory diseases, and other diseases[1]. | |||||||||
| CAS | 6951-57-1 | |||||||||
| Formula | C17H16O6 | |||||||||
| Molar Mass | 316.31 | |||||||||
| Appearance | 固体 | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Jianfeng Zhou; et al. Novel application of flavanone compound. CN106580951. 2016-11-17 |
PPARγ agonist 14
CAS: 6951-57-1 F: C17H16O6 W: 316.31
PPARγ agonist 14 (compound 3) is a PPARy agonist (EC50=2.4 μM) with anti-diabetic activity. PPARγ agonist 14 can impr
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.